|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 315.30 CHF | -0.94% |
|
-1.00% | -3.93% |
| 10:51am | Roche Holding AG - Analyst/Investor Day | |
| 12/05 | Roche Receives CE Mark For Elecsys Ptau217 Blood Test For Alzheimer?S Disease Pathology | CI |
| Capitalization | 26TCr 33TCr 28TCr 24TCr 45TCr 31,38900Cr 45TCr 3,05500Cr 1,19000Cr 14,88900Cr 1,23100Cr 1,20500Cr 51,73200Cr | P/E ratio 2026 * |
17x | P/E ratio 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise value | 27TCr 34TCr 29TCr 25TCr 47TCr 32,67900Cr 47TCr 3,18100Cr 1,23900Cr 15,50100Cr 1,28100Cr 1,25400Cr 53,85900Cr | EV / Sales 2026 * |
4.26x | EV / Sales 2027 * | 3.97x |
| Free-Float |
88.75% | Yield 2026 * |
3.12% | Yield 2027 * | 3.2% |
Last Transcript: Roche Holding AG
Trading Roche Holding AG
| 1 day | -0.94% | ||
| 1 week | -1.00% | ||
| Current month | -0.97% | ||
| 1 month | -0.10% | ||
| 3 months | -12.34% | ||
| 6 months | +8.57% | ||
| Current year | -3.93% |
| 1 week | 313 |  | 324.2 |
| 1 month | 312 | | 326.7 |
| Current year | 291 | | 374.9 |
| 1 year | 243.9 | | 374.9 |
| 3 years | 212.9 | | 374.9 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.94% | -1.00% | +20.39% | +10.73% | 33TCr | |
| +2.37% | +0.10% | +31.01% | +127.85% | 88TCr | |
| +1.28% | -0.57% | +45.49% | +39.48% | 54TCr | |
| +2.51% | +0.85% | +9.36% | +41.26% | 37TCr | |
| +1.82% | +3.14% | +33.84% | +14.47% | 29TCr | |
| +1.93% | +2.08% | +26.42% | +25.26% | 28TCr | |
| +0.98% | -0.69% | +39.71% | -4.07% | 28TCr | |
| -1.17% | +3.71% | -32.83% | -49.56% | 21TCr | |
| +2.03% | +2.03% | +22.39% | +44.36% | 18TCr | |
| +1.06% | +1.09% | +29.97% | +72.62% | 17TCr | |
| Average | +1.00% | +1.07% | +22.58% | +32.24% | 35.21TCr | |
| Weighted average by Cap. | +1.15% | +0.63% | +26.30% | +49.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.27TCr 8.02TCr 6.84TCr 5.94TCr 11TCr 7,67700Cr 11TCr 75TCr 29TCr 3,64200Cr 30TCr 29TCr 12,65300Cr | 6.53TCr 8.35TCr 7.12TCr 6.18TCr 11TCr 7,99400Cr 12TCr 78TCr 30TCr 3,79200Cr 31TCr 31TCr 13,17400Cr |
| Net income | 1.48TCr 1.89TCr 1.61TCr 1.4TCr 2.59TCr 1,81000Cr 2.62TCr 18TCr 6.86TCr 86TCr 7.09TCr 6.95TCr 2,98200Cr | 1.58TCr 2.02TCr 1.72TCr 1.5TCr 2.77TCr 1,93400Cr 2.8TCr 19TCr 7.33TCr 92TCr 7.58TCr 7.42TCr 3,18700Cr |
| Net Debt | 1.05TCr 1.35TCr 1.15TCr 998.04Cr 1.85TCr 1,29000Cr 1.87TCr 13TCr 4.89TCr 61TCr 5.06TCr 4.95TCr 2,12600Cr | 271.39Cr 346.95Cr 295.91Cr 256.89Cr 476.08Cr 33TCr 480.63Cr 3.23TCr 1.26TCr 16TCr 1.3TCr 1.27TCr 55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 321.50 CHF | +0.66% | 6,54,692 |
| 11/26/11 | 319.40 CHF | +1.30% | 7,24,136 |
| 08/26/08 | 315.30 CHF | -0.94% | 5,90,249 |
| 07/26/07 | 318.30 CHF | -1.12% | 6,90,846 |
| 06/26/06 | 321.90 CHF | +1.07% | 8,06,860 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition